News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.

Subscribe

To Purchase # 12060S

12060S 500 µg $169.00
$0.00

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

Western blot analysis of extracts from Jurkat cells, serum-starved overnight and untreated or treated with TPA #4174 (100 nM, 15 min) either with or without Gö6976 pretreatment (1 hr) at the indicated concentrations, using Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb #4668 (upper) or SAPK/JNK (56G8) Rabbit mAb #9258 (lower).

Learn more about how we get our images

Chemical Structure of Gö6976.

Learn more about how we get our images
Image

Product Usage Information

Gö6976 is supplied as a lyophilized powder. For a 1 mM stock, reconstitute the 500 µg in 1.32 ml DMSO. Working concentrations and length of treatment can vary depending on the desired effect, but it is typically used as a pretreatment at 0.1-10 µM for 0.5-1 hr prior to treating with a stimulator or is used alone with varying treatment times lasting up to 24 hr. Soluble in DMSO at 25 mg/ml; very poorly soluble in ethanol and water with maximum solubility in water at ~1-5 µM.


Storage: Store lyophilized or in solution at -20ºC, desiccated. Protect from light. In lyophilized form, the chemical is stable for 24 months. Once in solution, use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight:

378.43 g/mol


Purity:

>99%


Molecular Formula:

C24H18N4O


Gö6976 is an ATP-competitive PKC inhibitor specific for Ca2+-dependent PKCα (IC50 = 2.3 nM) and PKCβ1 (IC50 = 6.2 nM) isozymes (1). It is also a potent inhibitor of PKD (IC50 = 20 nM) (2). Researchers have demonstrated that Gö6976 blocks JNK activation (3-5) and inhibits PKCα-mediated, TPA-stimulated phosphorylation of CREB at Ser133 (6,7). Gö6976 is also an effective inhibitor of the tyrosine kinases Jak2 and FLT3 (8), as well as TrkA and TrkB (9).


1.  Martiny-Baron, G. et al. (1993) J Biol Chem 268, 9194-7.

2.  Gschwendt, M. et al. (1996) FEBS Lett 392, 77-80.

3.  López-Bergami, P. et al. (2005) Mol Cell 19, 309-20.

4.  Wen, J. et al. (2011) J Neuroinflammation 8, 38.

5.  Lemonnier, J. et al. (2004) J Biol Chem 279, 259-64.

6.  Chung, Y.W. et al. (2011) J Biol Chem 286, 29681-90.

7.  Paruchuri, S. and Sjölander, A. (2003) J Biol Chem 278, 45577-85.

8.  Grandage, V.L. et al. (2006) Br J Haematol 135, 303-16.

9.  Behrens, M.M. et al. (1999) J Neurochem 72, 919-24.



For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

12060
Gö6976